Trades on 1 secondary market

Somite

Somite (now operating as Cellular Intelligence) is an AI-native TechBio company backed by Khosla Ventures building a universal virtual cell-signaling foundation model to engineer cellular fate. In 2026 the company rebranded from Somite to Cellular Intelligence and entered an agreement with Novo Nord

minimal 8.1 / 100 0 APIs View provider profile →

Company Biotechnology Cell Therapy Artificial Intelligence Life Sciences Regenerative Medicine

Somite is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.